Skip to main content

Linking KPIs to ERP in speciality chemicals

14th November 2023

Submitted by:

Andrew Warmington

Sergey Nozhenko, a solution expert in SAP’s chemicals industry business unit, explains how value management can help speciality chemicals businesses assess and continually improve upon the ROI of their core IT outlays

Show me the money. It seems a simple enough request – or, perhaps better, demand - but it is one that has been asked imperfectly over the decades of enterprise resource processing (ERP) system implementations in the speciality chemicals business.

That ERPs have delivered value is beyond question. The user base serves as a testament to that – and try running a modern chemicals business without one. What can and should be questioned, however, is whether the value ERPs deliver on their substantial investments is being accurately quantified. That may sound like an accounting exercise. It should be a strategic imperative.

Such quantification must derive from business outcomes, and those are typically spelled out in key performance indicators (KPIs). For speciality chemical companies, KPIs span the business: sustainability, customer experience, R&D, asset management, capital project management, manufacturing, finance, procurement, supply chain and human resources count among the main focus areas.

Some KPIs are well entrenched. For example, in asset management, you have mainstays such as unplanned downtime, days in inventory, wrench time and asset maintenance-related KPIs. In speciality chemicals, where value trumps volume, KPIs may include innovation and product-development targets for higher added value. The rise of sustainability-related KPIs across the chemicals industry – but in particularly in speciality chemicals – serve as testament to KPIs changing over time as business priorities evolve.

ERPs deliver KPI values and outcomes in real time

The relationship ERPs have to KPIs is similarly evolving. In the past, ERPs have served largely as sources for raw or partially distilled data inputs for the spreadsheet-based derivation of KPIs. Now and going forward, cloud-based ERPs that tap into real-time databases can pull from diverse data sources and constantly track KPI status against goals.

Such immediate visibility can be powerful, both as a business driver on many fronts as well as in justifying the investments speciality chemicals companies continue to make in ERP systems themselves. That can trigger a virtuous cycle of ROI-justified IT investment, which, in turn, further improves business outcomes. But to get there, chemical companies must rethink how they go about vetting, justifying, and evaluating their IT investments.

Traditional value assessment

Investing millions of dollars in ERP integrations and enhancements has never been a trivial act in the chemicals business. Up-front ROI calculations have always been part of the story. The approach went roughly as follows:

* Define the scope of the IT programme

* Estimate the programme costs over time

* Come up with KPIs and their expected value

* Run the numbers (in terms of IRR, ROI & NPV)

* Approve the programme (or not)

An ERP is an investment that should be evaluated like any other production and business asset based on its estimated future impact. While the problem with this approach has also technology, the people and process aspects of business transformation have been bigger issues.

Too often, the breakdown in show-me-the-money happens because the executives who greenlight the project based on expected outcomes do not take responsibility for measuring and attaining those outcomes down the road. Rather, they see it as the project managers’ purview. As a result, the expected values of the KPIs that helped justify the ERP project in the first place may never actually get measured.

Technology also comes into play. The ERP functionality should ideally also include the data collection and algorithms that let the system itself produce the KPI results upon, which not only the business, but also the ROI of the ERP investment, is to be measured.

In other words, a properly planned ERP can do a lot to justify itself. But you have to do the people-process work up front. Otherwise, understanding KPI status after the fact can involve rooting out data from various shop-floor systems and dedicating time to massaging it into meaningful information using spreadsheets. The work involved is often taxing enough to dissuade the effort, and even when completed, the results tend to be stale.

It is no surprise that executives lacking evidence of the value of ERP functionality can mistake it for just another administrative system. There is an element of tragedy to that, especially because there is a better way.

The value management cycle

To understand and grow the value of their ERP investments, SAP’s chemical customers are embracing what we call the continuous value management cycle. The concept works with any ERP. It boils down to not only defining KPIs to justify the technology investment, but also making clear up front how that data will be collected, calculated and presented, with the ERP doing the heavy lifting.

Let’s say that a speciality chemicals maker decides that improved equipment-utilisation percentage and first-pass yield are its target KPIs. The ERP and associated systems should provide shop-floor integration for data gathering, a manufacturing data lake for data processing, and a business-analytics tool for converting equipment utilisation data and yield into efficiency-related and financial outputs for presentation in management dashboards.

Once operational, the progress informing those KPIs feed into the assessment of the ERP’s ROI and, vitally, are factored into the compensation of the executives who approved the IT investment in the first place. That ensures that they keep paying attention to the system they approved. With automated KPIs being delivered by ERP systems, executives can push for continuous improvement of the business functions those KPIs measure, and the positive reinforcement begins.

Given that none of this would be possible without ERP-derived KPIs, their contribution to the business is quantifiable. Along the way, ERPs take on importance to the business more than commensurate with the investments in them and the C-suite recognises as much. Finally, the ‘cycle’ in value management cycle is crucial.

Value management is an ongoing process; one that can apply to new ERP features as well as to existing business and production processes whose KPIs management dashboards show to be falling short. In those cases, too, people and process steps precede technology investments. Business process improvement or excellence teams deploy to unearth inefficiencies and their root causes using business-processes intelligence, propose solutions, and develop KPI improvements those solutions should yield.

Speciality chemical businesses must quickly, consistently, and accurately measure their effectiveness across multiple dimensions if they hope to continuously improve their businesses and stay competitive, profitable and sustainable. Not long ago, doing so would have been incredibly difficult – if possible at all – and certainly cost-prohibitive. Now we have the technologies and methodologies to make it real.

ERPs developed and augmented using a value management approach can deliver KPI-related insights quickly, transparently, and with real business impact. Not least, the ERP’s delivery of KPI-based insights shows management the money in terms of concrete return on ERP investment – and that’s a lot more satisfying than the marketing soundbites someone promised them before the ERP transformation project began.

Contact:

Serghey Nozhenko

SAP

[email protected]

Feature article – Saltigo rides out the cycle

Market and sustainability trends are positive drivers for Saltigo, despite the agro downturn. Andrew Warmington met up with the new CEO at Chemspec Europe

Submitted by:

Andrew Warmington

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical active ingredient (AI) manufacturing to its wholly owned subsidiary UPL Spec

Submitted by:

Andrew Warmington

Nippon Shokubai opens Indonesian plant

Japan’s Nippon Shokubai has officially opened a 100,000 tonnes/year acrylic acid (AA) plant that was built at a cost of about $200 million at Cilegon, Banten, Indonesia.

Submitted by:

Andrew Warmington

CABB to invest at Finnish agro site

The CABB Group has said that it will invest over €50 million by 2025 to expand facilities at its agrochemical manufacturing site in Kokkola, Finland.

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production planning of superabsorbent polymers (SAPs) based on acrylic acid, and has started operati

Submitted by:

Andrew Warmington

adcs

Three invest further into ADCs

Three CDMOs have separately announced expansions in their antibody-drug conjugate (ADC) manufacturing capabilities and capacity on opposite sides of the Atlantic.

Submitted by:

Andrew Warmington

Cambrex exits drug product

CDMO Cambrex has sold its Drug Product business unit to Noramco. Terms were not disclosed.

Submitted by:

Andrew Warmington

Siegfried breaks ground on R&D centre

Siegfried has broke ground for its new global R&D centre for drug substances at its site in Evionnaz, Switzerland.

Submitted by:

Andrew Warmington

Drug product centre opens

Following two years of construction work, CDMO Siegfried has officially opened its new development centre for drug products at its sites in Barberà del Vallès and El Masnou near Barcelona.

Submitted by:

Andrew Warmington

Evonik realigns Health Care

In order to “maximise customer centricity and market focus” and continue an ongoing transition into “a system solutions partner for the pharmaceutical and biotech industries”, Evonik has divided it

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants under the trade names AmphiCare and AmphiClean.

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based subsidiary of Seqens.

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in Austria have co-developed a computer-assisted regression model to improve enzyme performance and

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU and the Bio-based Industries Consortium (BIC) that funds projects advancing competitive circular bi

Submitted by:

Andrew Warmington

Investment in Tanasote plant

Octowood, a part of the Sweden’s Rundvirke Industrier Group, has invested in a new treatment plant using Arxada’s wood preservative, Tanasote.

Submitted by:

Andrew Warmington

Rhamnolipid milestone reached

Evonik has manufactured the first product from its industrial-scale biosurfactants facility at Slovenská Lupca in Slovakia.

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach Group in a move that it said would “create a global pigment company, combining SCIL’s ope

Submitted by:

Andrew Warmington

Lanxess to continue pigment production

Lanxess has reversed a decision to sell the chromium oxide pigments business at the Krefeld-Uerdingen site in Germany, preserving 50 jobs there.

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw materials, has announced a strategic collaboration with Japan’s Takasago, a large player in th

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site in Guangzhou. This triples its manufacturing capacity for fragrances and establis

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable fragrance ingredients from renewable carbon, with US-based LanzaTech, which describes i

Submitted by:

Andrew Warmington

Kao boosts jasmine fragrance

Japan's Kao Corporation is to double capacity for the synthetic fragrance methyl dihydrojasmonate (MDJ) at its site in Olesa, Spain, by adding a second production facility.

Submitted by:

Andrew Warmington

Merck KGaA “in a strong strategic position”

At its latest Capital Markets Day, Merck KGaA said that it is “in a strong strategic position” to profit from medium-term growth opportunities in all three of its business sectors after a transitio

Submitted by:

Andrew Warmington

Suez joins Global Impact Coalition

Suez, which describes itself as “a global leader in circular solutions for water and waste”, has joined the Global Impact Coalition (GIC).

Submitted by:

Andrew Warmington

Chemours opens battery lab

Chemours has opened Chemours Battery Innovation Centre (CBIC) at the Chemours Discovery Hub in Newark, Delaware.

Submitted by:

Andrew Warmington